Dr. John W Kugler MD
Hematologist-Oncologist | Hematology & Oncology
8940 N Wood Sage Rd Peoria IL, 61615About
Dr. John Kugler is a hematologist oncologist practicing in Peoria, IL. Dr. Kugler specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Univ of Ne Coll of Med, Omaha Ne 1979
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
- Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.
- Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer.
- Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
- A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer.
- Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity.
- 5-Fluorouracil-based chemotherapy for advanced colorectal cancer in elderly patients: a north central cancer treatment group study.
- Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
- Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer.
- A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer.
- A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancer.
- Pure red cell aplasia associated with administration of sustained-release procainamide.
- Measurable or assessable disease in lung cancer trials: does it matter?
- Phase II evaluation of 5-fluorouracil and low-dose leucovorin in cisplatin-refractory advanced ovarian carcinoma.
- Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group.
Dr. John W Kugler MD's Practice location
Dr. John W Kugler MD's reviews
Write ReviewPatient Experience with Dr. Kugler
Recommended Articles
- The Lymphoma Research Foundation's Light it Red for Lymphoma Night
Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...
- Is Lymphoma-related PTSD Possible?
PTSD is something that one may not think of right away when thinking of chronic or life-threatening illnesses, but it should not be overlooked. Post-traumatic stress disorder, or PTSD, can affect all aspects of a person’s life and requires treatment by a specialist.The Diagnostic and Statistical...
- Morphos Declared a "Breakthrough Therapy" for Lymphoma
MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...
- Tips on How to Live with Multiple Myeloma
Multiple myeloma, a type of cancer, adversely affects plasma cells, which are your immune system’s components. The American Cancer Society indicates that in 2014, more than 24,000 people in the United States had multiple myeloma.Multiple myeloma patients can lose their appetite due to the adverse...
- Stem Cell Therapy Puts 4-year-old's Ultra Rare Lymphoma in Remission
4-year-old Jovon Moss was diagnosed with X-linked Lymphoproliferative Syndrome, a rare disorder of the immune system that led him to being taken back and forth to the hospital since his 3rd birthday.Jovon’s journey began in September of last year, when his mother, Brittany Fluellen, first began to...
- The Promising Future of Gene Therapy and Lymphoma
Non-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...
Nearby Providers
- Dr. Diane J Prager MD8940 N Wood Sage Rd Peoria IL 61615
- Dr. Ankita K Patel M.DOsf St Francis Ctr Peoria IL 61637
- Dr. Allen M Vukov MD8940 N Woodsage Road Peoria IL 61615
- Dr. Nguyet A Le-lindqwister MD8940 N Wood Sage Rd Peoria IL 61615
- Dr. Jijun Liu MD8940 N. Wood Sage Road Peoria IL 61615
- Dr. Daniel Forman DOS Sixth Ave & Spruce St Reading PA 19611